A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets

NCT04275050 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Solid Tumor

Interventions

DRUG: TQB3303

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.